{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:21:55Z","timestamp":1761895315303},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s10165-011-0500-1","type":"journal-article","created":{"date-parts":[[2011,7,19]],"date-time":"2011-07-19T16:33:31Z","timestamp":1311093211000},"page":"308-311","source":"Crossref","is-referenced-by-count":4,"title":["Etanercept for the treatment of intractable hemophagocytic syndrome with systemic lupus erythematosus"],"prefix":"10.1093","volume":"22","author":[{"given":"Hirotoshi","family":"Kikuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurumi","family":"Asako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Shirasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,7,20]]},"reference":[{"key":"500_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1568-9972(03)00091-0","volume":"3","author":"C Larroche","year":"2004","unstructured":"Larroche C, Mouthon L. Pathogenesis of hemophagocytic syndrome (HPS). Autoimmune Rev. 2004;3:69\u201375.","journal-title":"Autoimmune Rev"},{"key":"500_CR2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.7326\/0003-4819-114-5-387","volume":"114","author":"KF Wong","year":"1991","unstructured":"Wong KF, Hui PK, Chan JKC, Chan YW, Ha SY. The acute lupus hemophagocytic syndrome. Ann Intern Med. 1991;114:387\u201390.","journal-title":"Ann Intern Med"},{"key":"500_CR3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/s10165-004-0293-6","volume":"14","author":"S Kumakura","year":"2004","unstructured":"Kumakura S, Ishikura H, Kondo M, Murakawa Y, Masuda J, Kobayashi S. Autoimmune-associated hemophagocytic syndrome. Mod Rheumatol. 2004;14:205\u201315.","journal-title":"Mod Rheumatol"},{"key":"500_CR4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10067-006-0245-y","volume":"26","author":"J Qian","year":"2007","unstructured":"Qian J, Yang CD. Hemophagocytic syndrome as one of main manifestations in untreated systemic lupus erythematosus: two case reports and literature review. Clin Rheumatol. 2007;26:807\u201310.","journal-title":"Clin Rheumatol"},{"key":"500_CR5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/01.md.0000224708.62510.d1","volume":"85","author":"O Lambotte","year":"2006","unstructured":"Lambotte O, Khellaf M, Harmouche H, Bader-Meunier B, Manceron V, Goujard C, et al. Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syndrome. Medicine. 2006;85:169\u201382.","journal-title":"Medicine"},{"key":"500_CR6","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.berh.2008.08.006","volume":"22","author":"B Fautrel","year":"2008","unstructured":"Fautrel B. Adult-onset Still disease. Best Pract Res Clin Rheumatol. 2008;22:773\u201392.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"500_CR7","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1093\/rheumatology\/kem205","volume":"46","author":"H Ideguchi","year":"2007","unstructured":"Ideguchi H, Ohno S, Takase K, Hattori H, Kirino Y, Takeno M, et al. Successful treatment of refractory lupus-associated haemophagocytic lymphohistiocytosis with infliximab. Rheumatology. 2007;46:1621\u20132.","journal-title":"Rheumatology"},{"key":"500_CR8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajh.20462","volume":"81","author":"T Henzan","year":"2006","unstructured":"Henzan T, Nagafuji K, Tsukamoto H, Miyamoto T, Gondo H, Imashuku S, Harada M. Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis. Am J Hematol. 2006;81:59\u201361.","journal-title":"Am J Hematol"},{"key":"500_CR9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s10165-007-0006-z","volume":"18","author":"N Takahashi","year":"2008","unstructured":"Takahashi N, Naniwa T, Banno S. Successful use of etanercept in the treatment of acute lupus hemophagocytic syndrome. Mod Rheumatol. 2008;18:72\u20135.","journal-title":"Mod Rheumatol"},{"key":"500_CR10","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/rheumatology\/keg187","volume":"42","author":"A Aouba","year":"2003","unstructured":"Aouba A, De Bandt M, Aslangul E, Atkhen N, Patri B. Haemophagocytic syndrome in a rheumatoid arthritis patient treated with infliximab. Rheumatology. 2003;42:800\u20132.","journal-title":"Rheumatology"},{"key":"500_CR11","first-page":"401","volume":"30","author":"AV Ramanan","year":"2003","unstructured":"Ramanan AV, Schneider R. Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis. J Rheumatol. 2003;30:401\u20133.","journal-title":"J Rheumatol"},{"key":"500_CR12","first-page":"2416","volume":"33","author":"T Matsui","year":"2006","unstructured":"Matsui T, Ohsumi K, Ozawa N, Shimada K, Sumitomo S, Shimane K, et al. CD64 on neutrophils is a sensitive and specific marker for detection of infection in patients with rheumatoid arthritis. J Rheumatol. 2006;33:2416\u201324.","journal-title":"J Rheumatol"},{"key":"500_CR13","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s10156-005-0388-9","volume":"11","author":"N Aikawa","year":"2005","unstructured":"Aikawa N, Fujishima S, Endo S, Sekine I, Kogawa K, Yamamoto Y, et al. Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother. 2005;11:152\u20139.","journal-title":"J Infect Chemother"},{"key":"500_CR14","first-page":"4100","volume":"89","author":"Y Osugi","year":"1997","unstructured":"Osugi Y, Hara J, Tagawa S, Takai K, Hosoi G, Matsuda Y, et al. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood. 1997;89:4100\u20133.","journal-title":"Blood"},{"key":"500_CR15","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood-2004-08-2997","volume":"105","author":"AD Billiau","year":"2005","unstructured":"Billiau AD, Roskams T, Damme-Lombaerts RV, Matthys P, Wouters C. Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-\u03b3-producing lymphocytes and IL-6- and TNF-\u03b1-producing macrophages. Blood. 2005;105:1648\u201351.","journal-title":"Blood"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-011-0500-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:25:23Z","timestamp":1646843123000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-011-0500-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,20]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["500"],"URL":"https:\/\/doi.org\/10.1007\/s10165-011-0500-1","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,20]]}}}